We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$373M
(+5.3%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$55.7M |
| 2 |
iShares Gold Trust
IAU
|
+$31.5M |
| 3 |
Hyatt Hotels
H
|
+$22.1M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20.2M |
| 2 |
Celldex Therapeutics
CLDX
|
+$15.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.52M |
| 4 |
Palantir
PLTR
|
+$4.79M |
| 5 |
RTX Corp
RTX
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.28% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.4% |
| 4 | Financials | 3.36% |
| 5 | Communication Services | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
PolyPid
PYPD
$92.8M
| $91K | ﹤0.01% |
391
| – | – |
|
1077
Mizuho Financial
MFG
$130B
| $88K | ﹤0.01% |
30,913
+16,592
| +116% | +$47.8K |
|
|
DRD
1078
DRDGold
DRD
$2.05B
| $84K | ﹤0.01% |
10,058
-1,037
| -9% | -$10K |
|
|
CLVS
1079
DELISTED
Clovis Oncology, Inc.
CLVS
| $82K | ﹤0.01% |
18,367
+1,394
| +8% | +$6.71K |
|
1080
Stereotaxis
STXS
$141M
| $81K | ﹤0.01% |
15,000
| – | – |
|
|
CRON
1081
Cronos Group
CRON
$1.14B
| $79K | ﹤0.01% |
13,951
-242
| -2% | -$1.64K |
|
|
ADAM
1082
Adamas Trust
ADAM
$883M
| $78K | ﹤0.01% |
4,465
+121
| +3% | +$2.1K |
|
1083
Odyssey Marine Exploration
OMEX
$51.8M
| $77K | ﹤0.01% |
10,958
| – | – |
|
|
LX
1084
LexinFintech Holdings
LX
$241M
| $76K | ﹤0.01% |
+12,917
| New | +$99.5K |
|
1085
NatWest
NWG
$76.4B
| $76K | ﹤0.01% |
+11,461
| New | +$71.3K |
|
|
ACB
1086
Aurora Cannabis
ACB
$185M
| $75K | ﹤0.01% |
1,082
-10
| -0.9% | -$711 |
|
|
ELP
1087
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $72K | ﹤0.01% |
+13,871
| New | +$67.1K |
|
|
EVLO
1088
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $70K | ﹤0.01% |
500
| – | – |
|
1089
Enel Chile
ENIC
$6.28B
| $69K | ﹤0.01% |
28,258
+16,481
| +140% | +$42.1K |
|
|
ENDP
1090
DELISTED
Endo International plc
ENDP
| $66K | ﹤0.01% |
20,494
+4,899
| +31% | +$17.3K |
|
|
SDC
1091
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $62K | ﹤0.01% |
+11,825
| New | +$73.4K |
|
1092
New Oriental
EDU
$8.98B
| $60K | ﹤0.01% |
2,939
+743
| +34% | +$23.6K |
|
|
AGEN
1093
Agenus
AGEN
$290M
| $57K | ﹤0.01% |
556
+18
| +3% | +$2.03K |
|
1094
Turkcell
TKC
$4.79B
| $54K | ﹤0.01% |
12,266
-8,863
| -42% | -$40.9K |
|
1095
Precigen
PGEN
$2.59B
| $53K | ﹤0.01% |
+10,588
| New | +$61K |
|
1096
Kosmos Energy
KOS
$1.48B
| $49K | ﹤0.01% |
16,527
| – | – |
|
1097
Fuel Tech
FTEK
$43.7M
| $44K | ﹤0.01% |
25,000
| – | – |
|
1098
Ensysce Biosciences
ENSC
$7.99M
| $42K | ﹤0.01% |
+4
| New | +$78.2K |
|
|
TRVG
1099
trivago
TRVG
$397M
| $34K | ﹤0.01% |
2,768
-58
| -2% | -$806 |
|
|
PVL
1100
Permianville Royalty Trust
PVL
$57.1M
| $32K | ﹤0.01% |
+16,671
| New | +$30.8K |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.
- Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
- Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
- Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
- Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
- Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
- Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
- Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.
Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.